應該
72%
不應該
28%
無意見
0%
認同
60%
不認同
33%
無意見
7%
股號 | 公司名稱 | 上市日期 | 集資額 | 上市價 | 按盤價 | 首日升跌 | 累積升跌 |
02592 | 撥康視雲-B 跌穿上市價 | 2025/07/03 | HKD 6.119億 | 10.100 | 5.640 | -3.900 (-38.614%) | -4.460 (-44.158%) |
02566 | 九源基因 跌穿上市價 | 2024/11/28 | HKD 5.639億 | 12.420 | 9.820 | -4.770 (-38.406%) | -2.600 (-20.934%) |
02576 | 太美醫療科技 跌穿上市價 | 2024/10/08 | HKD 3.351億 | 13.000 | 4.700 | -3.800 (-29.231%) | -8.300 (-63.846%) |
02565 | 派格生物醫藥-B 創52週高 跌穿上市價 | 2025/05/27 | HKD 3.008億 | 15.600 | 15.300 | -4.040 (-25.897%) | -0.300 (-1.923%) |
02530 | 紐曼思 跌穿上市價 | 2025/01/10 | HKD 2.000億 | 0.800 | 0.680 | -0.110 (-13.750%) | -0.120 (-15.000%) |
02561 | 維昇藥業-B 跌穿上市價 | 2025/03/21 | HKD 7.833億 | 68.800 | 49.000 | 0.000 (0.000%) | -19.800 (-28.779%) |
03880 | 泰德醫藥 | 2025/06/30 | HKD 5.141億 | 30.600 | 33.900 | +0.200 (+0.654%) | +3.300 (+10.784%) |
06681 | 腦動極光-B | 2025/01/08 | HKD 5.832億 | 3.220 | 5.650 | +0.110 (+3.416%) | +2.430 (+75.466%) |
02651 | 大眾口腔 跌穿上市價 | 2025/07/09 | HKD 2.172億 | 20.000 | 16.940 | +0.700 (+3.500%) | -3.060 (-15.300%) |
02506 | 訊飛醫療科技 | 2024/12/30 | HKD 5.825億 | 82.800 | 110.300 | +4.200 (+5.072%) | +27.500 (+33.213%) |
02593 | 草姬集團 跌穿上市價 | 2024/12/19 | HKD 1.250億 | 3.750 | 1.820 | +0.390 (+10.400%) | -1.930 (-51.467%) |
02410 | 同源康醫藥-B | 2024/08/20 | HKD 5.793億 | 12.100 | 19.780 | +1.600 (+13.223%) | +7.680 (+63.471%) |
01276 | 恒瑞醫藥 | 2025/05/23 | HKD 98.901億 | 44.050 | 68.050 | +11.100 (+25.199%) | +24.000 (+54.484%) |
02629 | MIRXES-B | 2025/05/23 | HKD 10.862億 | 23.300 | 30.800 | +6.700 (+28.755%) | +7.500 (+32.189%) |
02563 | 華昊中天醫藥-B 跌穿上市價 | 2024/10/31 | HKD 2.334億 | 16.000 | 8.010 | +4.800 (+30.000%) | -7.990 (-49.938%) |
02508 | 聖貝拉 | 2025/06/26 | HKD 7.220億 | 6.580 | 7.170 | +2.220 (+33.739%) | +0.590 (+8.967%) |
02587 | 健康之路 | 2024/12/30 | HKD 1.950億 | 7.800 | 8.200 | +2.860 (+36.667%) | +0.400 (+5.128%) |
02609 | 佰澤醫療 | 2025/06/23 | HKD 5.617億 | 4.220 | 6.680 | +1.780 (+42.180%) | +2.460 (+58.294%) |
02617 | 藥捷安康-B 創52週高 | 2025/06/23 | HKD 2.009億 | 13.150 | 37.250 | +10.350 (+78.707%) | +24.100 (+183.270%) |
09606 | 映恩生物-B | 2025/04/15 | HKD 16.396億 | 94.600 | 340.000 | +110.400 (+116.702%) | +245.400 (+259.408%) |
報價延遲最少15分鐘,更新:25/07/2025 16:41
首日升跌:首日收市價與上市價之比較。
累積升跌:按盤價與上市價之比較。
股價將因應送股及拆細作出調整。
公司透過介紹上市,首日開市價將當作為上市價。